Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 3826 AL 3840

Correction: Levodopa Intestinal Gel Infusion Therapies in Advanced Parkinson's Disease: A Swedish Study on Real-World Use and Costs

Odin P, Tærud C, Samuelsson J, Sabelström E, Lagerlund J, Freilich J, Stelmaszuk MN.

Neurol Ther. 2025 Oct;14(5):1861. doi: 10.1007/s40120-025-00797-9.

The PD COMM Process Evaluation: Describing Interventions and Implementation in a UK Pragmatic Randomised Controlled Trial of Speech and Language Therapy for People With Parkinson's-Related Dysarthria

Nicoll A, Brady MC, Masterson-Algar P, Burton C, Beaton G, Dickson S, Caulfield M, Smith CH, Clarke CE, Ives N, Jowett S, Rick C, Woolley R, Sackley CM; on behalf of the PD COMM collaborative group.

Int J Lang Commun Disord. 2025 Jul-Aug;60(4):e70084. doi: 10.1111/1460-6984.70084.

Micro(nano)plastics in the brain: Epigenetic perturbations in progression to neurodegenerative diseases

Mondal M, Chouksey A, Gurjar V, Tiwari R, Srivasatava RK, Mishra PK.

Neurotoxicol Teratol. 2025 Jul-Aug;110:107521. doi: 10.1016/j.ntt.2025.107521. Epub 2025 Jul 8.

Rethinking Parkinson's disease therapy: The overlooked role of GPR143 in L-DOPA effects

Aubignat M.

Rev Neurol (Paris). 2025 Sep;181(7):595-596. doi: 10.1016/j.neurol.2025.07.001. Epub 2025 Jul 9.

Causal relationship between immune mediators and parkinson's disease: A Mendelian randomization analysis

Qiu R, Su Y, Pan L, Fan K, Sun Z, Liang Y, Lin X, Zhang Y.

Sci Rep. 2025 Jul 10;15(1):24884. doi: 10.1038/s41598-025-11198-1.

Investigational Gene Therapies for Parkinson's Disease

Phielipp N, Henchcliffe C.

CNS Drugs. 2025 Aug;39(8):725-737. doi: 10.1007/s40263-025-01203-6. Epub 2025 Jul 10.

Biomarkers and therapeutic strategies targeting microglia in neurodegenerative diseases: current status and future directions

Noh MY, Kwon HS, Kwon MS, Nahm M, Jin HK, Bae JS, Kim SH.

Mol Neurodegener. 2025 Jul 10;20(1):82. doi: 10.1186/s13024-025-00867-4.

Accessory Pathway Antegrade Electrophysiologic Features Among Wolff-Parkinson-White Patients: The Risk in Relation to the Location

Atta S, Aboelhassan M, Ibraheem MK, Taha S.

J Cardiovasc Electrophysiol. 2025 Sep;36(9):2264-2270. doi: 10.1111/jce.70008. Epub 2025 Jul 10.

Lipid metabolism in microglia: Emerging mechanisms and therapeutic opportunities for neurodegenerative diseases (Review)

Sun Y, Wei K, Liao X, Wang J, Gao L, Pang B.

Int J Mol Med. 2025 Sep;56(3):139. doi: 10.3892/ijmm.2025.5580. Epub 2025 Jul 11.

Elevated Levels of Extracellular Vesicle-Associated TAOK1 in Plasma: A Diagnostic Marker for Cognitive Decline in Parkinson's Disease Dementia and Alzheimer's Disease

Kung PJ, Tsai YT, Yu RL, Lin-Wang HH, Kuo MC, Wu CC, Hong CT, Ueda K, Lin SP, Wu RM.

Mov Disord. 2025 Oct;40(10):2269-2271. doi: 10.1002/mds.30287. Epub 2025 Jul 11.

Exploring the diversity of biological processes regulated by glial cell line-derived neurotrophic factor, a pleiotropic molecule with therapeutic potential

Porcari C, Cattaneo S, Crippa L, Simonato M, Bettegazzi B.

Front Physiol. 2025 Jun 26;16:1618330. doi: 10.3389/fphys.2025.1618330. eCollection 2025.

It Is Time for Drug Repurposing in Parkinson Disease

Colosimo C, Marsili L.

Neurology. 2025 Aug 12;105(3):e213972. doi: 10.1212/WNL.0000000000213972. Epub 2025 Jul 11.

Association of Medication Use and 8-Year Mortality Risk in Patients With Parkinson Disease: Drug-Wide Trial Emulation

Tuominen JA, Riise T, Romanowska J, Flores-Torres MH, Cortese M, Scherzer CR, Bjornevik K, Igland J.

Neurology. 2025 Aug 12;105(3):e213783. doi: 10.1212/WNL.0000000000213783. Epub 2025 Jul 11.

Gut-brain-immune interactions: exploring probiotics as a drug delivery platform for neurological disease

Gudi CR, Wannemuehler MJ, Mansell TJ.

Adv Drug Deliv Rev. 2025 Sep;224:115650. doi: 10.1016/j.addr.2025.115650. Epub 2025 Jul 9.

Capturing α-synuclein aggregation interactors using UltraID-LIPA

Reddy K, Dieriks BV.

Trends Neurosci. 2025 Aug;48(8):557-559. doi: 10.1016/j.tins.2025.07.002. Epub 2025 Jul 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias